A question I have is why the commercialisation of its product has not translated into any significant revenue?
If not mistaken, knee replacement is a fairly common surgery. If ATI and ACI have been approved in Australia, why have they not been adopted widely among the patients given its less-invasive and more sustainable treatments?
Cheers,
Tim
A question I have is why the commercialisation of its product...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.020(3.23%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 64.5¢ | 62.0¢ | $200.9K | 319.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1459 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 6981 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |